EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.14.14.14 | aromatase |
SAOS-2 cell |
- |
745452 |
1.2.1.36 | retinal dehydrogenase |
SAOS-2 cell |
- |
724697 |
2.1.1.348 | mRNA m6A methyltransferase |
SAOS-2 cell |
- |
755980 |
2.3.1.255 | N-terminal amino-acid Nalpha-acetyltransferase NatA |
SAOS-2 cell |
- |
756332 |
2.3.1.48 | histone acetyltransferase |
SAOS-2 cell |
- |
703846 |
2.3.1.7 | carnitine O-acetyltransferase |
SAOS-2 cell |
- |
703113 |
2.4.1.50 | procollagen galactosyltransferase |
SAOS-2 cell |
- |
757159 |
2.4.2.26 | protein xylosyltransferase |
SAOS-2 cell |
equal expression levels of XT-I and XT-II |
702090 |
2.4.2.28 | S-methyl-5'-thioadenosine phosphorylase |
SAOS-2 cell |
- |
687178 |
2.7.1.1 | hexokinase |
SAOS-2 cell |
- |
737609 |
2.7.1.127 | inositol-trisphosphate 3-kinase |
SAOS-2 cell |
- |
760741 |
2.7.1.153 | phosphatidylinositol-4,5-bisphosphate 3-kinase |
SAOS-2 cell |
- |
751184 |
2.7.1.74 | deoxycytidine kinase |
SAOS-2 cell |
- |
721969 |
2.7.11.13 | protein kinase C |
SAOS-2 cell |
- |
703455 |
2.7.11.2 | [pyruvate dehydrogenase (acetyl-transferring)] kinase |
SAOS-2 cell |
- |
760702 |
2.7.11.21 | polo kinase |
SAOS-2 cell |
osteosarcoma cell line |
703011 |
2.7.11.22 | cyclin-dependent kinase |
SAOS-2 cell |
- |
679021 |
2.8.2.1 | aryl sulfotransferase |
SAOS-2 cell |
osteosarcoma cell line |
645678 |
2.8.2.1 | aryl sulfotransferase |
SAOS-2 cell |
predominantly contains SULT1A1 activity |
645678 |
3.1.3.1 | alkaline phosphatase |
SAOS-2 cell |
- |
94629 |
3.1.3.1 | alkaline phosphatase |
SAOS-2 cell |
osteosarcoma cells, contain isozymes of the bone alkaline phosphatase form, main isozymes are B1 and B2, and intestinal alkaline phosphatase form, e.g. isozyme B/I which is composed of 70% bone and 30% intestinal enzyme |
650752 |
3.1.3.1 | alkaline phosphatase |
SAOS-2 cell |
SAOS-2 cells |
94588 |
3.1.3.66 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase |
SAOS-2 cell |
- |
751184 |
3.1.3.75 | phosphoethanolamine/phosphocholine phosphatase |
SAOS-2 cell |
mineralizing osteoblast-like cells, PHOSPHO1 gene expression profile |
655132 |
3.1.3.75 | phosphoethanolamine/phosphocholine phosphatase |
SAOS-2 cell |
osteoblast-like cells |
654549 |
3.1.3.75 | phosphoethanolamine/phosphocholine phosphatase |
SAOS-2 cell |
osteoblast-like cells, expression of PHOSPHO1 |
657232 |
3.1.4.1 | phosphodiesterase I |
SAOS-2 cell |
- |
730170 |
3.1.4.11 | phosphoinositide phospholipase C |
SAOS-2 cell |
- |
135132, 670440, 716113 |
3.1.4.11 | phosphoinositide phospholipase C |
SAOS-2 cell |
isoenzyme PI-PLC-ß1 |
668867 |
3.1.4.17 | 3',5'-cyclic-nucleotide phosphodiesterase |
SAOS-2 cell |
PDE1 |
668213 |
3.1.4.53 | 3',5'-cyclic-AMP phosphodiesterase |
SAOS-2 cell |
PDE4 |
668213 |
3.1.4.53 | 3',5'-cyclic-AMP phosphodiesterase |
SAOS-2 cell |
PDE7 |
668213 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
SAOS-2 cell |
- |
731576 |
3.4.21.B12 | prostase |
SAOS-2 cell |
KLK4 mRNA and protein is not significantly changed in SaOs2 cells treated with conditioned media from either PC-3 cells or LNCaP cells. KLK4 mRNA is clearly increased following direct co-culture of SaOs2 cells with either PC-3 orLNCaP cells |
689848 |
3.4.22.15 | cathepsin L |
SAOS-2 cell |
- |
710810 |
3.4.22.62 | caspase-9 |
SAOS-2 cell |
treated with doxycycline (2 microg/ml in PBS) |
699440 |
3.4.22.B26 | calpain 6 |
SAOS-2 cell |
- |
717676 |
3.4.22.B71 | SENP2 peptidase |
SAOS-2 cell |
- |
753521 |
3.4.24.35 | gelatinase B |
SAOS-2 cell |
- |
707953 |
3.4.24.B15 | PHEX peptidase |
SAOS-2 cell |
osteoblast cell culture |
649294 |
3.4.24.B3 | matrix metalloproteinase-11 |
SAOS-2 cell |
- |
694496 |
3.4.24.B9 | ADAM9 endopeptidase |
SAOS-2 cell |
osteosarcoma cell line |
653737 |
3.5.1.13 | aryl-acylamidase |
SAOS-2 cell |
- |
754722 |
3.6.1.23 | dUTP diphosphatase |
SAOS-2 cell |
- |
758298 |
3.6.1.9 | nucleotide diphosphatase |
SAOS-2 cell |
mineralizing osteoblastic cells |
667143 |